Djibouti vs Mauritania: Antiretroviral therapy coverage for PMTCT
Djibouti
38.0%
in 2024
Mauritania
39.0%
in 2024
Djibouti rank
74th
Mauritania rank
73rd
Antiretroviral therapy coverage for PMTCT over time
- Djibouti
- Mauritania
How they compare
Mauritania currently reports 39.0% against 38.0% in Djibouti, a difference of 1.0%.
The two have swapped places 6 times across 25 shared years of data; in 2000 it was Mauritania ahead.
Djibouti ranks 74th and Mauritania ranks 73rd of 84 countries.
Djibouti has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Djibouti | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.4% | 2.0% | 4.4% | Djibouti |
| 2010s | 28.2% | 25.1% | 3.1% | Djibouti |
| 2020s | 34.0% | 28.4% | 5.6% | Djibouti |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Djibouti or Mauritania?
- Mauritania, at 39.0% against 38.0% in Djibouti as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Djibouti and Mauritania?
- 1.0%, with Mauritania ahead.
- How many years of comparable data are there for Djibouti and Mauritania?
- 25 years are reported by both, from 2000 to 2024.
- How do Djibouti and Mauritania rank globally for antiretroviral therapy coverage for pmtct?
- Djibouti ranks 74th and Mauritania ranks 73rd of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).